A nurse is collecting data from a client who is taking sumatriptan. Which of the following reports indicates a therapeutic response to the medication?

D. The Quadrivalent human papillomavirus (HPV) vaccine is recommended for both males and females to protect against certain strains of HPV that can lead to cervical cancer, genital warts, and other HPV- related cancers. It is typically administered in a series of doses starting around 11-12 years of age.
A. Hepatitis B vaccine is typically administered at birth, followed by a series of doses at 1-2 months and 6-18 months of age. By the age of 11, the child would have completed the series if they were up to date on immunizations. Therefore, it is unlikely that the child would need another dose of the Hepatitis B vaccine at this age.
B. Rotavirus vaccine is usually administered in infancy, with the first dose given around 2 months of age and the last dose by 8 months of age. By the age of 11, the child would have completed the series if they were up to date on immunizations. So, administering the Rotavirus vaccine to an 11-year-old who is up to date on immunizations is unnecessary.
C. The Pneumococcal conjugate vaccine protects against infections caused by the bacterium Streptococcus pneumoniae, such as pneumonia and meningitis. It is typically administered in infancy, with a booster dose recommended at around 12-15 months of age. However, the CDC recommends a single revaccination dose of Pneumococcal conjugate vaccine for children aged 6 through 18 years who are at high risk of infection. If the child falls into this category, the nurse should plan to administer the vaccine.

D. The absence of headache indicates a therapeutic response to sumatriptan. Sumatriptan is specifically indicated for the acute treatment of migraine attacks with or without aura and the acute treatment of cluster headache episodes. The absence of headache indicates that sumatriptan has effectively relieved the headache symptoms.
A. Improved mood is not a direct therapeutic response to sumatriptan. While relieving headache pain may contribute to an improved mood, sumatriptan primarily targets headache symptoms rather than mood regulation.
B. Increased bone mass is not a therapeutic response to sumatriptan. Sumatriptan does not affect bone metabolism or bone mass. Therefore, changes in bone mass would not be related to sumatriptan therapy.
C. Sumatriptan is not used in the management of chest pain.